Skip to content

Cadre Holdings, Inc.

CDRE · XNYS

CIK 1860543fmd_1MFED73KJE691KPRGGA8NPM92PManufacturing · Orthopedic, Prosthetic & Surgical Appliances & SuppliesTemplate: Standard

Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods

Income Statement · Annual · Millions · USD
Line itemFY2020FY2021FY2022FY2023FY2024FY2025
Total revenues405427458483568610
Cost of revenue252257282282334351
Gross profit153171176201233260
Research and development6677811
Selling, general and administrative107115153141158183
Total operating expenses103119159144167192
Operating income505217576767
Interest expense2416658–
Other non-operating income (expense)(22)(33)(7)(4)(13)(5)
Income before taxes28199535462
Income tax expense(11)74141818
Net income from continuing operations38136393644
Net income38136393644
Net income to common shareholders38136393644
Cadre Holdings, Inc. (CDRE) financial statements · FinancialMD